Oriola-KD Oyj B
Oriola Oyj provides healthcare and wellbeing products primarily in Sweden and Finland. It also offers vitamins, food and food supplements, sports nutrients, wound care, beauty, and makeup related products. In addition, it provides pharmaceutical logistics and dose dispensing services. Further, the company engages in the wholesale of traded goods and over-the counter products, and special licensed… Read more
Oriola-KD Oyj B (OKDBV) - Net Assets
Latest net assets as of March 2025: €132.60 Million EUR
Based on the latest financial reports, Oriola-KD Oyj B (OKDBV) has net assets worth €132.60 Million EUR as of March 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€963.50 Million) and total liabilities (€830.90 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €132.60 Million |
| % of Total Assets | 13.76% |
| Annual Growth Rate | -1.6% |
| 5-Year Change | -21.34% |
| 10-Year Change | -31.45% |
| Growth Volatility | 26.61 |
Oriola-KD Oyj B - Net Assets Trend (2004–2024)
This chart illustrates how Oriola-KD Oyj B's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Oriola-KD Oyj B (2004–2024)
The table below shows the annual net assets of Oriola-KD Oyj B from 2004 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €133.40 Million | -22.12% |
| 2023-12-31 | €171.30 Million | -24.07% |
| 2022-12-31 | €225.60 Million | +4.06% |
| 2021-12-31 | €216.80 Million | +27.83% |
| 2020-12-31 | €169.60 Million | +7.89% |
| 2019-12-31 | €157.20 Million | -13.39% |
| 2018-12-31 | €181.50 Million | -8.19% |
| 2017-12-31 | €197.70 Million | -3.65% |
| 2016-12-31 | €205.20 Million | +5.45% |
| 2015-12-31 | €194.60 Million | +71.30% |
| 2014-12-31 | €113.60 Million | -59.15% |
| 2013-12-31 | €278.10 Million | -11.69% |
| 2012-12-31 | €314.90 Million | +5.21% |
| 2011-12-31 | €299.30 Million | -15.14% |
| 2010-12-31 | €352.70 Million | +33.09% |
| 2009-12-31 | €265.00 Million | +42.86% |
| 2008-12-31 | €185.50 Million | -8.89% |
| 2007-12-31 | €203.60 Million | +6.15% |
| 2006-12-31 | €191.80 Million | +2.95% |
| 2005-12-31 | €186.30 Million | +1.09% |
| 2004-12-31 | €184.30 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Oriola-KD Oyj B's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 1820000000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €18.20 Million | 13.64% |
| Other Components | €115.20 Million | 86.36% |
| Total Equity | €133.40 Million | 100.00% |
Oriola-KD Oyj B Competitors by Market Cap
The table below lists competitors of Oriola-KD Oyj B ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Rongfeng Holding Group
SHE:000668
|
$159.03 Million |
|
Dat Phuong JSC
VN:DPG
|
$159.08 Million |
|
Hennessy Capital Investment Corp. VII Unit
NASDAQ:HVIIU
|
$159.10 Million |
|
Ibersol SGPS
LS:IBS
|
$159.16 Million |
|
Shandong Sino-Agri United Biotechnology Co Ltd
SHE:003042
|
$158.97 Million |
|
Cypherpunk Holdings Inc
OTCQX:CYFRF
|
$158.92 Million |
|
Bafang Yunji Intl Co Ltd
TW:2753
|
$158.92 Million |
|
TASKUS INC. CL.A DL-01
F:6VY
|
$158.91 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Oriola-KD Oyj B's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 171,300,000 to 133,400,000, a change of -37,900,000 (-22.1%).
- Net loss of 20,100,000 reduced equity.
- Dividend payments of 12,700,000 reduced retained earnings.
- Share repurchases of 100,000 reduced equity.
- Other comprehensive income decreased equity by 84,200,000.
- Other factors increased equity by 79,200,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-20.10 Million | -15.07% |
| Dividends Paid | €12.70 Million | -9.52% |
| Share Repurchases | €100.00K | -0.07% |
| Other Comprehensive Income | €-84.20 Million | -63.12% |
| Other Changes | €79.20 Million | +59.37% |
| Total Change | €- | -22.12% |
Book Value vs Market Value Analysis
This analysis compares Oriola-KD Oyj B's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.51x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has increased from 0.85x to 1.51x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2006-12-31 | €1.30 | €1.11 | x |
| 2007-12-31 | €1.38 | €1.11 | x |
| 2008-12-31 | €1.30 | €1.11 | x |
| 2009-12-31 | €1.66 | €1.11 | x |
| 2010-12-31 | €2.33 | €1.11 | x |
| 2011-12-31 | €1.98 | €1.11 | x |
| 2012-12-31 | €2.08 | €1.11 | x |
| 2013-12-31 | €1.84 | €1.11 | x |
| 2014-12-31 | €0.71 | €1.11 | x |
| 2015-12-31 | €1.10 | €1.11 | x |
| 2016-12-31 | €1.13 | €1.11 | x |
| 2017-12-31 | €1.09 | €1.11 | x |
| 2018-12-31 | €1.00 | €1.11 | x |
| 2019-12-31 | €0.87 | €1.11 | x |
| 2020-12-31 | €0.93 | €1.11 | x |
| 2021-12-31 | €1.20 | €1.11 | x |
| 2022-12-31 | €1.24 | €1.11 | x |
| 2023-12-31 | €0.94 | €1.11 | x |
| 2024-12-31 | €0.74 | €1.11 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Oriola-KD Oyj B utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -15.07%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -1.20%
- • Asset Turnover: 1.92x
- • Equity Multiplier: 6.56x
- Recent ROE (-15.07%) is below the historical average (-2.01%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2005 | 10.11% | 1.29% | 2.18x | 3.61x | €190.00K |
| 2006 | 5.24% | 1.45% | 1.08x | 3.34x | €-8.72 Million |
| 2007 | 11.92% | 1.69% | 2.13x | 3.30x | €3.75 Million |
| 2008 | 14.99% | 1.74% | 2.00x | 4.31x | €9.15 Million |
| 2009 | 19.97% | 2.84% | 1.86x | 3.79x | €24.26 Million |
| 2010 | 28.95% | 5.29% | 1.62x | 3.38x | €66.83 Million |
| 2011 | -8.05% | -1.12% | 1.69x | 4.25x | €-54.03 Million |
| 2012 | 5.46% | 0.70% | 1.88x | 4.19x | €-14.29 Million |
| 2013 | 2.09% | 0.22% | 1.73x | 5.39x | €-22.01 Million |
| 2014 | -186.88% | -13.17% | 1.84x | 7.69x | €-223.66 Million |
| 2015 | 22.92% | 2.74% | 1.72x | 4.87x | €25.14 Million |
| 2016 | 20.86% | 2.61% | 1.77x | 4.51x | €22.28 Million |
| 2017 | 13.30% | 1.72% | 1.66x | 4.67x | €6.53 Million |
| 2018 | 7.00% | 0.82% | 1.67x | 5.11x | €-5.45 Million |
| 2019 | 5.09% | 0.46% | 1.67x | 6.56x | €-7.72 Million |
| 2020 | 6.66% | 0.63% | 1.54x | 6.87x | €-5.66 Million |
| 2021 | 5.21% | 0.60% | 1.72x | 5.04x | €-10.38 Million |
| 2022 | 2.13% | 0.32% | 1.58x | 4.26x | €-17.76 Million |
| 2023 | -12.08% | -1.39% | 1.60x | 5.46x | €-37.83 Million |
| 2024 | -15.07% | -1.20% | 1.92x | 6.56x | €-33.44 Million |
Industry Comparison
This section compares Oriola-KD Oyj B's net assets metrics with peer companies in the Pharmaceutical Retailers industry.
No peer company data available for comparison.